These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23508275)

  • 1. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
    Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
    Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
    Xu DM; van der Zaag-Loonen HJ; Oudkerk M; Wang Y; Vliegenthart R; Scholten ET; Verschakelen J; Prokop M; de Koning HJ; van Klaveren RJ
    Radiology; 2009 Jan; 250(1):264-72. PubMed ID: 18984780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning.
    Ashraf H; Dirksen A; Loft A; Bertelsen AK; Bach KS; Hansen H; Pedersen JH; Mortensen J
    Thorax; 2011 Apr; 66(4):315-9. PubMed ID: 21169285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation.
    Qi LL; Wu BT; Tang W; Zhou LN; Huang Y; Zhao SJ; Liu L; Li M; Zhang L; Feng SC; Hou DH; Zhou Z; Li XL; Wang YZ; Wu N; Wang JW
    Eur Radiol; 2020 Feb; 30(2):744-755. PubMed ID: 31485837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
    Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
    Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
    Byrne SC; Hammer MM
    AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352
    [No Abstract]   [Full Text] [Related]  

  • 11. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry.
    Oda S; Awai K; Murao K; Ozawa A; Utsunomiya D; Yanaga Y; Kawanaka K; Yamashita Y
    Acad Radiol; 2011 Jan; 18(1):63-9. PubMed ID: 21145028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules.
    Revel MP; Merlin A; Peyrard S; Triki R; Couchon S; Chatellier G; Frija G
    AJR Am J Roentgenol; 2006 Jul; 187(1):135-42. PubMed ID: 16794167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study.
    Zhao YR; Heuvelmans MA; Dorrius MD; van Ooijen PM; Wang Y; de Bock GH; Oudkerk M; Vliegenthart R
    Radiology; 2014 Mar; 270(3):872-9. PubMed ID: 24475806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying CT texture analysis to determine the prognostic value of subsolid nodules detected during low-dose CT screening.
    Sun Q; Huang Y; Wang J; Zhao S; Zhang L; Tang W; Wu N
    Clin Radiol; 2019 Jan; 74(1):59-66. PubMed ID: 30501892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.
    Veronesi G; Travaini LL; Maisonneuve P; Rampinelli C; Bertolotti R; Spaggiari L; Bellomi M; Paganelli G
    Eur Respir J; 2015 Feb; 45(2):501-10. PubMed ID: 25261326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial.
    Heuvelmans MA; Oudkerk M; de Jong PA; Mali WP; Groen HJ; Vliegenthart R
    Eur Radiol; 2015 Mar; 25(3):792-9. PubMed ID: 25366707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
    Xu DM; van Klaveren RJ; de Bock GH; Leusveld AL; Dorrius MD; Zhao Y; Wang Y; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
    Eur J Radiol; 2009 Jun; 70(3):492-8. PubMed ID: 18417311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.